ENTERA BIO LTD. (ENTX) Return on equity 2020–2025
ENTERA BIO LTD. (ENTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-87.3%FY2025 · since FY2020: -149.3% → -87.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -87.3% | +30.8 pp |
| FY2024 | -118.1% | -32.5 pp |
| FY2023 | -85.6% | +25.6 pp |
| FY2022 | -111.2% | -57.2 pp |
| FY2021 | -54.0% | +95.3 pp |
| FY2020 | -149.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ENTX financial trends
ENTX RevenueENTX Net incomeENTX Net marginENTX Gross profitENTX Gross marginENTX Operating incomeENTX Operating marginENTX Operating cash flowENTX Free cash flowENTX Capital expendituresENTX Stock buybacksENTX Dividends paidENTX Total assetsENTX Total liabilitiesENTX Shareholders’ equityENTX overview →